GlassScriptPhysician profile
Bradley James Cohen
NPI 1801839113
$8,968.55
in general payments reported to CMS, 2019-2025
73 companies · none reported in 2025
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,551 · 2020: $1,445 · 2021: $480 · 2022: $3,316 · 2023: $121 · 2024: $55.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $872.86 | 2019-2022 | |
| Janssen Biotech, INC. | $669.02 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $570.88 | 2019-2024 | |
| Pfizer INC. | $553.65 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $526.99 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $483.41 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $421.71 | 2019-2022 | |
| Incyte Corporation | $260.61 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $249.60 | 2019-2022 | |
| Seagen INC. | $234.20 | 2019-2022 | |
| Lilly USA, LLC | $232.94 | 2019-2022 | |
| Eisai INC. | $231.70 | 2019-2022 | |
| Gilead Sciences, INC. | $213.48 | 2019-2022 | |
| Exelixis INC. | $196.81 | 2021-2022 | |
| Genentech USA, INC. | $181.64 | 2019-2020 |
Show all 72 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.